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Abstract: Aptamers are promising alternative binders 
that can substitute antibodies in various applications. 
Due to the advantages of aptamers, namely their high 
affinity, specificity and stability, along with the benefits 
originating from the chemical synthesis of aptamers, they 
have attracted attention in various applications includ-
ing their use on nanostructured material. This necessi-
tates the immobilization of aptamers on a solid support. 
Since aptamer immobilization may interfere with its bind-
ing properties, the immobilization of aptamers has to be 
investigated and optimized. Within this review, we give 
general insights into the principles and factors controlling 
the binding affinity of immobilized aptamers. Specific 
features of aptamer immobilization on nanostructured 
surfaces and nanoparticles are highlighted and a brief 
overview of applications of aptamer-modified nanostruc-
tured materials is given.
Keywords: applications; aptamer; immobilization; nano-
material; nanoparticle.
Introduction
Aptamers are synthetic short single stranded oligonucle-
otides composed of DNA or RNA. Based on their unique 
three-dimensional structure, aptamers exhibit specific 
binding to their corresponding target molecule, which can 
be a small molecule, a macromolecule, or a complete cell. 
Due to this specificity and their high affinity, aptamers 
can be used to substitute antibodies in different applica-
tions. In comparison to antibodies, aptamers offer several 
advantages which are mainly based on their in-vitro gen-
eration and their oligonucleotide nature: aptamers are 
selected in an in-vitro process termed systematic evolu-
tion of ligands by exponential enrichment (SELEX) [1]. 
Due to this animal-free process, aptamers can be selected 
to exhibit binding of the target under non-physiological 
conditions and the selection of aptamers is also possible 
for highly toxic or non-immunogenic molecules [2]. Once 
aptamers are selected and their sequence is revealed, they 
can be produced by chemical synthesis, a process not 
only resulting in high and consistent product quality, but 
also facilitating the precise introduction of labels or other 
modifications at defined positions within the aptamer 
sequence.
Aptamers have already been applied successfully e.g. 
for the detection of proteins and small molecules [3, 4], 
the purification of proteins [5–7] and depletion of small 
 molecules [8], as well as in cell targeting and drug delivery 
[9–11]. In most of the developed aptamer-based methods, 
the aptamer has to be immobilized on a solid support, 
which might be a nano-structured surface. Aptamer 
binding to the corresponding target molecule depends on 
the correct three-dimensional folding of the aptamer [12]. 
Therefore, it is crucial to immobilize aptamers without 
affecting their ability to fold into this binding-competent 
structure. Within the first section of this review article we 
will highlight factors that may interfere with correct folding 
of aptamers on solid supports and give general suggestions 
for the immobilization of functional aptamers.
Immobilization of aptamers
As mentioned before, functional groups can be incorporated 
into the aptamer sequence and can subsequently be used 
for the immobilization of the aptamer on a solid support. 
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For different types of materials, different modifications can 
be utilized, for example the introduction of terminal thiol 
groups is allowing for the straight-forward immobilization 
of aptamers on gold surfaces. Since the chemical synthesis 
enables precise control of the position of functional groups, 
the aptamer can be immobilized in a highly controlled ori-
entation, i.e. via one of the termini of the aptamer. This 
controlled orientation facilitates high binding activity by 
avoiding a loss of functionality resulting from immobiliza-
tion in random orientation. Nonetheless, several factors 
influencing aptamer folding have to be carefully considered 
during the immobilization of aptamers and in many cases, 
optimization of aptamer conjugation has to be performed to 
obtain functional aptamer-modified surfaces [13].
Effects of immobilization to aptamer 
performance
In order to immobilize aptamers in a functional manner, 
the conjugation process must not interfere with aptamer 
folding [14, 15]. Here, the user has to consider that during 
most of the selection processes, aptamers are present free 
in solution. Thus, aptamers can adopt their binding-com-
petent folding while they are in solution but might lose 
their binding competence after immobilization mainly 
due to three different factors [13]:
First, the surface may directly interfere with aptamer 
folding. This is especially problematic when truncated ver-
sions of the aptamer sequence are used. To overcome steric 
hindrance caused by too close proximity of aptamer and 
surface, the use of spacer molecules can be recommended. 
Here, rather simple spacers like polyethylen glycol moie-
ties can be used and either be provided on the surface 
or fused between the aptamer sequence and the aptamer 
modification used for immobilization chemistry [16]. Also 
the elongation of the aptamer sequence, e.g. by introduc-
tion of several thymin bases, can provide additional space 
to allow for proper aptamer folding. One other factor that 
might interfere with correct folding of the aptamer is its ori-
entation. Therefore, a screening of different aptamer orien-
tations (3′ terminal versus 5′ terminal immobilization) may 
be useful to optimize aptamer performance.
The second feature of aptamers that has to be consid-
ered is their highly negative charge. Immobilizing aptam-
ers on positively charged surfaces may result in complete 
unfolding of aptamers – which interact with the surface 
electrostatically. This can be prevented by capping of the 
surface [13].
Finally, the third factor influencing the folding of 
conjugated aptamers is the immobilization density. While 
generally, high immobilization densities are desired to 
guarantee high binding capacity for the aptamer target, 
too high aptamer density may prevent formation of the 
correct three-dimensional structure. Here, one has to con-
sider that the immobilized aptamer must be provided with 
sufficient space to fold encountering no steric interference 
caused by neighboring aptamers. Moreover, the negative 
charge of aptamers can provoke electrostatic repulsion 
of neighboring aptamers, thereby forcing the aptamers to 
erect into a rather linear conformation not able to bind the 
target molecule. Therefore, the aptamer density, which 
can be easily influenced by the aptamer concentration 
applied during the immobilization process, has to be opti-
mized experimentally.
Methods to investigate immobilized 
aptamers
As elaborated briefly in the previous subsection, several 
parameters including the aptamer density, aptamer orien-
tation, surface charge, and the presence of spacers influ-
ence the performance of immobilized aptamers. Thus, 
methods for the investigation and optimization of aptamer 
conjugation are needed. Surface plasmon resonance (SPR) 
measurements allow for the quantitative investigation 
of the binding affinities of immobilized aptamers. SPR 
measurements are especially useful to reveal immobili-
zation-induced reduction of aptamer affinity when they 
are compared with immobilization-free methods for the 
determination of dissociation constants such as isother-
mal titration calorimetry (ITC) or microscale thermopho-
resis (MST) [17]. The comparison of dissociation constants 
obtained by different methods may uncover negative 
effects evoked by immobilization. Nonetheless, SPR meas-
urements suffer from a limited degree of parallelization, 
thus require a large set of experiments to screen differ-
ent immobilization conditions and additionally require 
rather large amounts of aptamer and target. In our group, 
aptamer microarrays have shown to be a suitable alterna-
tive for the systematic investigation and optimization of 
aptamer immobilization [13, 16, 18]. Here, many different 
immobilization conditions (e.g. different aptamer orien-
tations and immobilization densities, as well as different 
spacer moieties) can be screened in parallel on one single 
microarray. When aptamers are utilized as a receptor 
probe in a biosensing scheme, depending on the type and 
complexity, optimization of aptamer-conjugation directly 
within the biosensing platform may be the most suitable 
approach. Aptamer performance can be set in relation 
with the output signal and optimized accordingly.
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Aptamer-modified nanostructured 
surfaces
Many different materials are accessible to a wide variety 
of surface chemistries for the attachment of biomole-
cules, such as aptamers. One reason for immobilization 
of aptamers to nanostructured surfaces specifically can 
be to increase the aptamer-density on the material due to 
higher surface area of such materials and thus increased 
area of interaction between aptamer and target analyte [19, 
20]. Another main reason are the desirable intrinsic prop-
erties of nanostructured materials in combination with 
the binding characteristics of the immobilized aptamers 
which are opening possibilities for a variety of applica-
tions. In the following chapter, we will discuss some of 
the main considerations when conjugating aptamers to 
nanomaterials and present a number of applications with 
their corresponding materials, where such concepts were 
realized in an outstanding manner.
Special considerations for aptamer immobili-
zation on nanostructured surfaces
Nanomaterials and nanostructured materials of different 
kinds have recently gained increased attention for their 
application in concert with aptamer-receptors tethered to 
their surface [21–23]. Applications thereof, see Tables 1 and 
2, can mainly be found in the field of biosensors and for 
the capture and purification of cellular targets (e.g. cancer 
cells, bacteria cells). However, in contrast to immobiliza-
tion of oligonucleotides on planar surfaces, aptamer-con-
jugation to nanomaterials requires a number of additional 
considerations which are discussed in the following.
Increased immobilization-density of aptamers conju-
gated to a surface (i.e. by means of larger surface area in 
nanomaterials), also brings the risk of higher steric hin-
drance effects, commonly occurring [4, 13, 38, 39]. This 
phenomenon was recently studied by Daniel et  al. on a 
planar gold-coated prism for SPR measurements with the 
thrombin-binding aptamer as model [39]. The research-
ers conducting the study consequently compared binding 
affinities of the thrombin to surface-immobilized aptam-
ers and in a competitive mode when additional aptam-
ers are present in solution. They varied grafting-density 
as well as concentrations of free aptamer and found that 
increasing grafting-density has a negative effect on the 
binding affinity (KD) of the surface-conjugated aptamer, 
while it has no effect on the KD of aptamer in solution. 
In order to ensure sufficient spacing and thus maintain 
aptamer-functionality, even on this planar surface, addi-
tional spacing between aptamer and surface had to be 
applied.
Nanoscale surface features (e.g. roughness, groves, 
pores) and spatial confinement of aptamers when immo-
bilized on nanomaterials adds another dimension to the 
challenge of controlling steric hindrance effects. Even 
though close proximity of capture probe and target sup-
ported by nanostructure architecture (e.g. in a porous 
matrix) can enhance their interaction [40], high grafting-
density and crowding within the nanostructures can 
hamper aptamer-functionality and accessibility of the tar-
get-binding sites [38, 41]. Herein, also electrostatic interac-
tions can have a particular effect: high amounts of negative 
charges accumulated by conjugated aptamers on a surface 
can prevent access of target analytes to the binding sites, 
which is enhanced by spatial confinement and limited free 
surface. Hence, besides reduced crowding, reduced nega-
tive charges can be a reason for better capture efficiency at 
Table 1: Aptamer-modified nanostructured surfaces for cell capture.
Aptamer-target   NS material   Immobilization   Application   Comments   References
Antiepithelial cell 
adhesion molecule
  Nano-structured glass slides  Phenyldiisothio-cyanate – NH2 
aptamer
  Circulating tumor 
cell capture
    [24]
EGFR (RNA aptamer)  Nanotextured PDMS   Silanization, isothiocyanate groups, 
NH2-DNA, prehybridization with 
salmon sperm, hybridization of RNA 
aptamer
  Circulating tumor 
cell capture
    [25]
T lymphocyte   Silicon nanowires   MPTMS, heterobifunctional linker 
(GMBS), DNA aptamer
  Cell capture   Release 
mechanism
  [26]
TD05   Polymer-modified silicon 
nanowires
  Click chemistry [copper-catalysed 
azide–alkyne cycloaddition (CuAAC)]
  Circulating tumor 
cell capture
    [27]
Lactobacillus 
acidophilus
  Porous SiO2   Acrydite-coupling on SH-surface   Optical biosensor    [28]
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lower aptamer immobilization densities [28, 38]. Further-
more, while enhanced surface roughness due to nanoscale 
features on the surface can improve interaction of the 
target (i.e. cells) with the substrate, it may also render it 
prone to unspecific adsorption (e.g. matrix components) 
[42, 43]. Thus, when nanomaterials are functionalized with 
aptamers, special attention has to be paid to careful opti-
mization of spacer-arms and immobilization density as 
well as to orientation of the aptamer (see Section “Effects 
of immobilization to aptamer performance”).
Exemplary applications of aptamer-tethering to nano-
structured surfaces are presented in the following.
Application of aptamer-modified nano-
structured surfaces
Cell capture
Circulating tumor cells (CTCs) are an interesting target 
for the early detection, understanding and therapy of 
different cancer types [44, 45]. Since they occur in low 
numbers in the blood stream of patients with solid 
tumors, there is a strong need for effective methods to 
enrich and isolate these cells [46–48]. Over the past few 
years, efficient approaches have been developed, many 
of which take advantage of highly specific aptamers that 
have been selected for targeted capture of such cells with 
high affinity. Combination of aptamer capture probes and 
nanostructured materials has brought forth a number of 
excellent studies taking advantage of increased surface 
roughness and receptor-density by means of the used 
nanomaterials or by appropriate treatment of substrates 
in order to create nanoscale features [49].
One example was presented by Wang et al. [24], dem-
onstrating an increase of target cell capture by almost 50% 
with only one additional step of nanostructuring their 
glass slides prior to functionalization with anti-EpCAM 
(epithelial cell adhesion molecule) aptamers for the spe-
cific capture of EpCAM-expressing PC3 cells. Aiming to 
mimic the surface roughness of extracellular matrix (with 
feature sizes between 260 and 410 nm [50]), Wang and col-
leagues exposed borosilicate glass to a reactive ion etching 
(REI) process yielding average features of 374.3 nm under 
optimized conditions. Such homogeneously nanostruc-
tured glass slides were then subject to further functionali-
zation and finally conjugation with aptamers before being 
studied for the effectiveness of cell capture onto them. As 
a result, the group showed a 76% cell-capture efficiency 
for the nanostructured slides in comparison to only 30% 
of PC3 cells captured on the planar slides.
In a similar study, Wan et al. [25] compared the specific 
capture of human glioblastoma and meninges-derived 
primary fibroblast cells (hGBM) by a RNA-aptamer, tar-
geting cell membrane overexpressed epidermal growth 
factor receptors (EGFRs) on planar and nanotextured 
polydimethylsiloxane (PDMS) substrate. While a treat-
ment with NaOH on the PDMS template resulted in an 
increased PDMS surface roughness (with feature sizes 
of about 289  nm after complete functionalization with 
RNA capture probes), untreated templates resulted in a 
PDMS substrate with minor features of 22 nm. Herein, the 
authors draw a direct connection of the surface roughness 
and the amount of subsequently immobilized aptamers. 
Thus, enhanced cell capture on the nanotextured PDMS 
was concluded to be a synergistic effect of increased 
aptamer density and simulation of basement membrane 
structure through appropriate roughness on the substrate, 
both promoting cell attachment.
Besides their excellent biocompatibility [51], silicon 
nanowires (SiNWs) have also shown high efficiency in cell 
capturing, especially when functionalized with specific 
aptamer-capture probes [26, 27]. Significantly increasing 
the aptamer density on the exposed substrate surface and 
through their topography preferred by cells, the nanow-
ire structures facilitate the contact between capture probe 
and cell receptors and provide a suitable 3D structure for 
cell contacts [52–55], see Figure 1C. Nanowires have dem-
onstrated capture efficiencies two orders of magnitude 
higher, in comparison to planar silicon substrates, and 
enable controlled release of captured cells through revers-
ible aptamer-folding [26]. While such a SiNW-system has 
been demonstrated for the capture of T-lymphocyte cells 
[26], an example of SiNWs grafted with Ramos-cell spe-
cific aptamers and glycopolymers, showed high capturing-
efficiency at notably low cell-concentrations and directly 
in serum-containing medium [27]. Herein, the utilized 
glycopolymer has a cell-affinity itself, binding glucose 
transporter proteins on the cell membrane, but only the 
combination with cell-specific aptamers created a highly 
efficient multifunctional surface for the capture of CTCs.
In the aforementioned examples, the aptamer-
functionalized nanostructures and their high surface 
to volume ratio, had the main purpose to promote cell 
attachment through cell-compatible roughness and 
nanoscale features. Not in all applications, where cells 
are captured, their detection based on labeling or cell 
staining is suitable. Instead, depending on the nature of 
the utilized nanomaterial, it can be additionally exploited 
as the signal transducer: visible white light reflection 
from Faby-Pérot thin films can easily be recorded with 
a spectrometer. Porous silicon thin films display such 
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light interferences and are commonly used for biosensing 
applications in a reflective interferometer Fourier trans-
form spectroscopy (RIFTS) mode [57–59], see Figure  1B. 
Additionally, cell capture on porous nanostructures has 
been reported [28, 60, 61]. The technique enables rapid 
capture and detection of cells with minimal instrumen-
tation and without the need of labeling. One example 
where the advantages of aptamers have been combined 
with optical porous silicon structures was recently dem-
onstrated for distinct capture of live probiotic bacteria 
[28]. Herein, the importance of spacing between aptamer 
and biosensor surface as well as immobilization density 
was highlighted as it directly affected optical signals and 
the ability of the structure to capture bacteria cells. The 
porous silicon matrix in concert with the tethered highly 
specific aptamers, showed fast and robust optical signals 
upon bacteria capture on the nanostructured surface and 
importantly, could distinguish between live and dead 
bacteria populations based on the specificity of the uti-
lized aptamer [28].
Due to the availability of aptamers against many 
other bacteria species, several systems for their capture 
have recently been reported (e.g. against Escherichia coli 
O157:H7 [62], Salmonella typhimurium [63] or Staphylococ-
cus aureus [64]), however, to the best of our knowledge, 
none of the so far published examples, harnesses the 
advantages of nanostructured surfaces, but are rather 
designed utilizing different types of nanoparticles.
Biosensing
A classification of biosensors is usually firstly made 
by separating label-free and label-based approaches. 
Secondly, biosensors of different signal transductions 
(optical, electrical etc.) can be divided. In the following, 
we are presenting several examples of biosensors, cover-
ing all types, and outlining their beneficial combination 
of nanomaterials and aptamer capture probes.
Contrary to the previously described cell capture 
methods, in biosensors, most schemes involving the use 
of nanomaterials, take advantage of them for the purpose 
of signal transduction and/or amplification. The most 
popular material, chosen not only for its intrinsic proper-
ties but also due to facile and well-characterized immo-
bilization of oligonucleotides, is probably gold. While it 
is being widely utilized as planar material for functional-
coating or as electrode material [65], researchers have also 
increased efforts in studying gold nanostructures due to 
their plasmonic properties as well as absorbance, cou-
pling and scattering properties which are depending on 
their geometry [29, 30, 37].
Figure 1: SEM micrographs of different nanomaterials.
 (A) Au-capped nanopillars [30]. (B) Porous silicon oxide structure cross section and top-view (inset) [4]. (C) Silicon nanowires top view 
and cross section (inset) [27]. (D) Au-hexagon structures [29]. (E) CPPy nanotube-networks on electrodes [32]. (F) Molybdenum selenide 
 flower-like nanostructures [56]. Adapted with permission from the respective references.
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Chemisorption of thiols to elemental gold is a well-
known mechanism resulting in stable self-assembled 
monolayers (SAM) [66, 67]. With the facile possibility of 
post-synthesis functionalization of oligonucleotides with 
thiols, the immobilization of thiolated DNA to gold in 
any form, has proven to be a viable strategy and remains 
widely utilized [68] as can be seen from the examples pre-
sented in the following.
Surface-enhanced Raman spectroscopy (SERS) is a 
promising technique for the sensitive detection of chemi-
cal or biological species. Herein, characteristic molecu-
lar vibrations are observed as the inelastic scattering of 
monochromatic light by surface-tethered species. The 
use of noble metal nanostructures (i.e. gold) enhances 
the signals obtained significantly due to (i) the localized 
surface plasmons on the gold surface that get excited 
and (ii) the formation of a target-analyte complex ena-
bling charge transfers [22, 29, 69]. It is crucial, that dis-
tinct Raman signals are observed only upon binding of 
the target molecule. One example by Peters et  al. [29], 
presents the detection of dopamine, also investigating the 
influence of different gold nano-geometries on the signal 
output. Herein, hexagonal Au is used as substrate for the 
immobilization of the capturing aptamer, see Figure  1D. 
Raman signals are observed only when the target is 
present and bound.
Unlike the previously mentioned assay, in an example 
by Yang et al. [30], an additional TAMRA-tag (5-carboxyte-
tramethylrhodamine) on the targeted vasopressin protein 
hormone is necessary to achieve distinct and enhanced 
Raman signals upon target capture. The authors of this 
study on a SERS biosensor pay specific attention to opti-
mization of the aptamer immobilization density, aptamer 
orientation and surface effects on the Au coated silicon 
nanopillars. One interesting aspect they emphasize, is 
the treatment of the gold layer with mercaptohexanol 
(MCH), which on the one hand blocks access of analyte 
and buffer components to the gold surface (causing 
unspecific adsorption), and on the other hand, supports 
the vertical orientation of the aptamers when conjugated 
to the surface (by preventing interaction of aptamer and 
gold surface, thereby enhancing functional structures). 
However, the authors do not report if they observed a 
ligand exchange induced by prolonged exposure to MCH. 
This is highly relevant when choosing utilized MCH con-
centrations and incubation times [30, 70]. Their hypoth-
esis is confirmed by significantly higher Raman peak 
intensities for samples treated with MCH. With their opti-
mized setup, highly reliable and quantitative detection of 
picomolar concentrations was achieved. In achieving sen-
sitive signals, the utilized nanostructure, namely silicon 
nanopillars, was of the essence: trapping target molecules 
between the nanopillars resulted in intense Raman scat-
tering enhanced by the localized plasmon resonance 
induced by the gold-capped pillars leaning towards each 
other, see Figure 1A.
Among the label-free methods, field effect transis-
tors (FET) have recently gained a lot of attention due to 
the advantages of nanostructured materials that can be 
integrated to the gate of the transistor [71]. In one example 
by So et al., the well-studied and in this case amine-mod-
ified thrombin-aptamer was conjugated to single walled 
carbon nanotubes (CNTs) within a FET via carbodiimida-
zole chemistry. Thanked to the small size of the aptam-
ers and the conducting properties of the nanotubes, the 
FET enabled robust thrombin detection at low nanomolar 
concentrations with the additional possibility of biosen-
sor regeneration for consecutive sensing cycles. It should 
be noted that in label-free FETs where the use of CNTs 
provides significant advantages, their nanostructure is 
not means of signal attainment, but a suitable and highly 
beneficial material enabling the observation of changes in 
its conductance upon target binding. Other nanomaterials 
such as graphene or SiNWs are also widely used as FET-
gate materials due to their tunable material properties [71]. 
Another novel nanomaterial that has been demonstrated 
for the use as FET-gate material are carboxylic-acid-func-
tionalized polypyrrole (CPPy) nanotubes. In a study by 
Yoon et al. [32], similarly as previously described for CNTs, 
the conducting polymer nanotubes, possessing a carboxy-
functionality, were conjugated to the electrodes and gate 
surface and subsequently modified with amine-termi-
nated aptamers targeting thrombin. Besides the facile 
synthesis of the material, its stable attachment to the FET 
basis and a reliable biosensing performance at thrombin 
concentrations between 50 and 500 nM, the authors show 
the beneficial effects of the formation of interconnected 
CPPy networks on the gate surface between source and 
drain electrode, evoking higher signal amplification as 
well as the improved sensor sensitivity at high aptamer-
densities [32], see Figure 1E.
Oxidized porous silicon (PSiO2) nanostructures 
serving as optical transducers are an example where the 
nanomaterial not only provides increased surface area 
but also facilitates signal transduction: when an aptamer 
is immobilized onto a PSiO2 structure, it can serve for the 
capture of target proteins while the induced changes in 
optical properties of the functionalized scaffold can be 
recorded with a spectrometer. This simple experimental 
setup was proven successfully with an aptamer directed 
against his-tagged proteins, demonstrating rapid protein 
detection in a reversible manner and with outstanding 
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simplicity [4]. Herein, the signal upon target capture, 
arises through the changes in refractive index of the 
nanostructured matrix induced by the formation of the 
aptamer-target complex. Noteworthy is the reversibility 
of the target binding and complete regeneration of the 
sensor for multiple consecutive biosensing cycles result-
ing in highly reproducible signals.
Likewise utilizing multifunctional porous silicon sub-
strates, Yoo et al. demonstrated a biosensor for the detec-
tion of adenosine [33]. Herein, the authors take advantage 
of the target induced dissociation of a TAMRA-labeled 
complementary strand from the aptamer-functionalized 
porous silicon surface. Thereby the fluorescence of the 
label, which was previously effectively quenched by the 
silicon surface properties, is restored and a fluorescence 
signal can be observed. The authors demonstrate this 
simple one-step assay with submicromolar concentra-
tions of adenosine and propose the application of this 
scheme for the detection of other biomolecules. Despite 
the simple design, the assay relies on a labeled compo-
nent impeding the reuse of the biosensor and additionally 
requires fluorescence detection which implies the neces-
sity of sophisticated laboratory instruments.
Electrochemical aptasensors for thrombin utilizing 
amperometry or impedance spectroscopy (EIS) as well as 
electrochemical quartz crystal microbalance (EQCM) have 
been studied extensively by the group of Hianik [34, 35, 
72–75]. Pre-treatment of their multiwalled CNTs (MWCNTs) 
with methylene blue (MG) has shown significant improve-
ments in sensitivity for most of their biosensing schemes 
[34, 35]. This is not attributed to a direct effect on the target 
affinity of the biosensor, but rather improved immobiliza-
tion of aptamers due to the MB’s positive charge counter-
balancing the negative charges of the carboxy-terminated 
MWCNTs and aptamers respectively. Thus, MWCNT-MB 
composites possess a higher aptamer-density after func-
tionalization and subsequently display lower detection 
limits. Furthermore, MB in its role as a phenothiazine 
dye provides means of signal detection by its change in 
redox-status upon interaction of immobilized aptamers 
and its target analyte. The group has demonstrated a wide 
range of detection schemes and consequently improved 
the performance of their biosensors. Noteworthy is also 
their investigation of so called aptabodies [73]. Heterodi-
mers of two anti-thrombin aptamers modified each with a 
poly-A or poly-T tag respectively form Y-shaped aptabod-
ies due to the complementarity of the tags, subsequently 
each possessing two binding sites for the target protein. 
Contrary to improved sensitivity in EQCM, investigations 
for EIS emphasize the fragile balance of aptamer density 
and steric hindrance phenomena as well as charge-related 
affinity losses: the authors were not able to further 
improve biosensor sensivity from their reported 0.3  nM 
for the EQCM biosensing scheme and assume a negative 
effect of the high density negative charges on the coordi-
nation of the binding motifs [34, 35].
Going beyond the commonly demonstrated thrombin 
model-systems, a highly relevant application of an elec-
trochemical aptasensor has been demonstrated by Miodek 
et  al. [36]. For the sensitive detection of human cellular 
prions, the authors combined several elements: a MWCNT-
coated gold surface served as electrode, while a layer of 
fourth generation polyamidoamine dendrimers coupled 
to the MWCNTs further increased available surface func-
tionalities for the following conjugation of modified ferro-
cene markers [76]. Finally, traditional biotin-streptavidin 
was used to immobilize prion specific aptamers. Binding 
of human cellular prions significantly impacted the elec-
tron transfer in the system, enabling specific detection of 
prions at concentrations as low as 0.5 pM and notably, 
applicability directly in blood plasma [36].
The range of the presented examples in this review 
makes no pretence to be complete, however, in the 
authors’ opinion it reflects the variety of nanomaterials, 
aptamer-immobilization strategies and different target 
analytes well and shall give the reader a good idea of the 
capabilities and limitations of currently studied aptasen-
sors employing nanostructured materials.
Combination of nanostructured surfaces and 
nanoparticles
In search of mechanisms to amplify attained signals and 
enhance specificity, some assays rely on sandwich formats 
where aptamer-conjugated nanoparticles can serve as 
secondary capture probes and labels [77, 78]. While the 
advantages and different applications for aptamer-func-
tionalized nanoparticles will be discussed in the next 
chapter, herein, we would like to give one example where 
both, a nanostructured material and nanoparticles are 
implemented with aptamer-assisted target capture.
In the study by Huang et al. [37], molybdenum sele-
nide nanoflowers were prepared by a simple hydrother-
mal method on the surface of an electrode. This material 
was chosen due to its high surface area, the exceptional 
intrinsic electrical conductivity and finally its electro-
catalytical activity induced by the selenite component, 
see Figure  1F. They constructed a highly sensitive elec-
trochemical sensor for the detection of ochratoxin A 
(OTA) by integration of oligonucleotide-functionalized 
gold nanoparticles (AuNPs). Therein, the aptamers were 
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also hybridized with a second complementary sequence. 
Methylene blue (MB) was utilized as the electrochemical 
probe due to its specific interaction with single stranded 
DNA (ssDNA). Upon target binding, complementary DNA 
was released and thus became available (as ssDNA) for 
interaction with MB. This can be observed by the change 
in redox currents. With this construction of a combination 
between nanostructured surfaces and additional nano-
particles, the authors achieved a highly sensitive assay 
with detection limits as low as 0.08 pM OTA.
Aptamer-modified nanoparticles
Special considerations for aptamer immobili-
zation on nanoparticles
For aptamer conjugation to nanoparticles, the surface 
charge of the nanoparticles has to be considered. Direct 
immobilization of aptamers on cationic surfaces, such 
as polyethylenimine (PEI), may lead to an aptamer-PEI-
complex which interferes with correct aptamer folding 
and thereby renders the aptamer useless as targeting mol-
ecule. Thus, nanoparticles composed of neutral material 
[e.g. polymers such as polylactic acid (PLA) or polylactic-
co-glycolic acid (PGLA)] may be most convenient for con-
jugation with aptamers [79].
An important goal during aptamer-immobilization 
is maintaining the binding affinity and selectivity the 
aptamer displays in solution [14]. This is usually accom-
plished by covalent binding of the aptamer to a surface 
bound linker and, in some cases, non-covalent attach-
ment by physisorption [14]. In the last few years, many 
advantages in synthesis and characterization of different 
nanoparticles such as metallic, silica, magnetic, hydrogel 
or polymeric nanoparticles and CNTs have been revealed 
[80]. These nanomaterials generally possess a large surface 
area in combination with a unique size and shape. Due 
to their small sizes, nanoparticles can potentially move 
through cell and tissue barriers and their cellular uptake 
can be compared much easier as for larger drug delivery 
systems [81, 82]. The large surface-area-to-volume ratio 
leads to a greater drug delivery efficiency [81]. Addition-
ally, the high surface area allows for high loading of tar-
geting or drug molecules [83]. Furthermore, nanoparticles 
display composition and size dependent physical proper-
ties such as SPR, fluorescence and/or magnetism [80].
One advantage of aptamer immobilization on nano-
particle surfaces, for example, is the influence of aptamer 
on the nanoparticle stability. Wang et  al. showed that 
gold nanoparticles were more stable in high salt con-
centrations when modified with aptamers [84]. High salt 
concentrations shield the electric field and un-modified 
nanoparticles form aggregates more frequently due to 
dipole interactions [85]. To stabilize gold nanoparticles 
against aggregation, negatively charged aptamers can be 
coupled to nanoparticle surfaces and prevent the aggre-
gation due to the electrostatic repulsion forces between 
similarly charged surfaces [85].
Application of aptamer-modified 
nanoparticles
The modification of nanoparticles with specific aptamers 
has proven advantageous in different areas of applica-
tions. The properties of aptamer-modified nanoparticles 
can among others be used for biosensing. If cell-specific 
aptamers are used, resulting conjugates can be used for 
cell targeting and targeted drug delivery [80].
There are four different types of nanoparticles con-
jugated with aptamers which are commonly used for bio-
logical imaging applications: Gold nanoparticles (AuNP), 
quantum dots (QD), silica nanoparticles (SiNP) and mag-
netic nanoparticles (MNP).
In the following, we present examples for applica-
tions of aptamer-modified nanoparticles in cell and intra-
cellular targeting, drug delivery and biosensing.
Cell targeting
One prominent application of aptamer-modified nano-
particles is cell targeting. To date, countless aptamers for 
various cellular targets are available. Targets can be cell-
surface bound proteins, viruses, and so on [86]. Table 3 
summarizes several applications of aptamer-modified 
nanoparticles along with the used aptamer, its target, the 
mode of detection and the type of NP.
Most applications aim to target cancer cells. Gao 
et  al. developed biodegradable nanoparticles consisting 
of polyethylene glycol (PEG) and polycaprolactone (PCL), 
which are also functionalized with AS1411 aptamer and 
loaded with doxorubicin (DOX). They were able to target 
and enhance cellular uptake by glioma cells in vitro [89].
Another example for cell targeting is found in litera-
ture: Farokhzad et al. developed a nanoparticle-aptamer 
bioconjugate for targeting prostate cancer cells. They 
synthesized nanoparticles consisting of poly(lactic 
acid)-block-polyethylene glycol (PLA-PEG) and coupled 
an aptamer to their surface which selectively binds to 
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prostate-specific membrane antigen (PSMA) [80, 93, 95]. 
Farokhzad and coworkers successfully demonstrated 
that their nanoparticle-aptamer conjugates targeted 
prostate cancer epithelial cells and were internalized by 
them [93].
The imaging and targeting of PSMA has also been 
realized by using superparamagnetic iron oxide nanopar-
ticles (SPION) functionalized with the A10 aptamer [88]. 
The A10 aptamer is an RNA aptamer specifically binding 
an extracellular domain of the PSMA. SPIONs are charac-
terized by low toxicity and detection limits, for example. 
An important application of SPIONs is to serve as a mag-
netic resonance imaging (MRI) contrast agent for cancer 
diagnosis [96]. As mentioned, Wang and coworkers 
developed A10 aptamer-modified thermally cross-linked 
SPIONs enabling the detection (by MRI) and treatment of 
PSMA [88].
Jalalian and coworkers developed epirubicin loaded 
SPIONs functionalized with 5TR1 aptamer, which binds 
specifically to mucin-1, a glycoprotein which is overex-
pressed on many epithelial tumors and adenocarcinomas 
[97]. They investigated the internalization of the aptamer-
modified particles and cell viability after incubation with 
drug loaded and modified particles. Detection of the inter-
nalization was performed by using flow cytometry analy-
sis. Cell viability was assessed by MTT assay [97].
Aptamer-modified QDs are used particularly for cancer 
cell imaging [98]. MUC-1 aptamer-conjugated QDs for the 
detection of mucin-1 positive cells serve as an example for 
fluorescent cell imaging [90]. QDs are also widely used 
for targeting breast cancer cells (MCF-7). Gedi and Kim 
 successfully targeted such cells with aptamer-modified 
QDs, resulting in a strong red fluorescence signal [99].
Ulusoy and coworkers developed aptamer-modified 
QDs for the detection and imaging of lung cancer cells 
[100]. They used the S15 aptamer directed against the 
lung cancer cell line A549 [101]. Fluorescence microscopy 
showed that aptamer-modified QDs were successfully 
internalized by lung cancer cells while unmodified QDs 
were not taken up [100].
Silica is a biocompatible but inorganic material 
often used for biological applications such as artificial 
implants [83]. It was found that silica is an appropriate 
compound for the development of drug releasing systems. 
Mesoporous silica nanoparticles (MSN) are responsive to 
external (e.g. light or magnetic field) and internal stimuli 
(e.g. enzymes or pH). They are also used for imaging, con-
trolled release of therapeutics and cell targeting. When 
MSNs are conjugated with aptamers, they can be used for 
targeting cancer cells [102]. Li and coworkers developed 
MSNs and conjugated them to AS1411 aptamer which is 
specific to nucleolin, a protein overexpressed on several 
types of cancer cells [89, 102]. The conjugated MSNs have 
successfully targeted MCF-7 cells [102, 103]. Investigating 
the success of cell targeting, Li and coworkers prepared 
fluorescein-modified MSNs, conjugated to AS1411 aptamer 
and then incubated them with MCF-7 cells. Utilizing con-
focal microscopy, the targeting and internalization of the 
particles were observed [102].
Su and coworkers coated MSNs with carbon quantum 
dots and conjugated them with aptamers for the electro-
luminescent detection of MCF-7 cells. The aptamer used 
was directed against mucin1. Specifically, Su et al. used a 
surface which was cast with a three dimensional graphene 
(3D-GR). Additionally, AuNPs were attached to the 3D-GR 
to improve the electronic transmission. Subsequently, 
MCF-7 cells were seeded on the modified electrode and 
were incubated with aptamer-modified MSNs. Detection 
was carried out with electrochemical impedance spectros-
copy [103].
Table 3: Overview about aptamers, their targets and types of nanoparticles on which they could be conjugated (continued).
Aptamer   Target   Detection   Type of NP   References
A9   Prostate-specific membrane 
antigen (PSMA)
    QD   [87]
A10   PSMA   Colorimetric   SPIONa   [88]
AS1411   Nucleolin   Fluorescent   Polymer-NP, MSN  [89–91]
MUC1   Mucin-1   Fluorescent   QD, SiNP   [90]
TTA1   Tenascin-C   Fluorescent   MNP   [92]
A30   HER-2   Fluorescent   AuNPb   [93]
Sgc8c   CCRP-CEM cells   Fluorescent   AgNPc   [1]
TD05   Ramos (B-cell lymphoma)   Fluorescent   QD   [90]
S6   A549   Fluorescent   Polymer-NP, QD   [90]
SA17, SA61  S. aureus   Light scattering  AuNPs   [94]
aSPION, Superparamagnetic iron oxide nanoparticle; bAuNP, gold nanoparticle; cAgNP, silver nanoparticle.
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MNP are widely used for cell targeting as biological 
samples mostly exhibit no magnetic properties. Thus, 
MNPs may yield ultrasensitive detection with no inter-
fering background signals [92]. MNPs conjugated with 
aptamers have been applied for cell targeting especially 
in cancer cell targeting. An example is the detection of 
Tenascin-C in glioma cells. Iliuk and coworkers used the 
GB-10 aptamer specifically binding to the Tenascin-C 
receptor on glioma cells and conjugated it to MNPs. The 
interaction between aptamer-modified MNPs and cancer 
cells was determined by scanning electron microscopy. 
Only aptamer-modified particles interacted with the 
glioma cells [104].
Not only cancer cells or their receptors can be tar-
geted, but also bacteria like Staphylococcus aureus [94]. 
Chang and coworkers selected two aptamers against S. 
aureus and conjugated them to AuNPs. They modified 
AuNPs with one of the selected aptamers (SA17 and SA61) 
and detected the interaction between aptamer-modified 
particles and S. aureus cells by direct detection (resonance 
light-scattering signals).
Aptamer-modified AuNPs are also used for the detec-
tion of Escherichia coli (E. coli) O157:H7 and Salmonella 
typhimurium (S. typhimurium). Aptamers can stabilize 
AuNPs against aggregation in presence of high salt con-
centrations. Furthermore, AuNPs change color when they 
aggregate. Wu and coworkers took advantage of these 
properties and modified AuNPs with aptamers. Subse-
quently, they incubated E. coli and S. typhimurium with the 
conjugates. The conformation of the aptamers changed 
upon binding to the bacteria. Thus, the particles could 
not be stabilized by aptamers anymore and after applying 
high salt-concentrations, AuNPs aggregated and the dis-
persion changed its color. Color change was detected by 
UV/Vis spectroscopy [105].
As illustrated by the presented applications, aptamer-
modified nanoparticles are very promising candidates for 
cell targeting and diagnostic detection. Especially in the 
context of in vivo imaging, there are still some problems to 
be solved. The main issue is the investigation of long term 
in vivo cytotoxicity.
Drug delivery
Drug delivery systems aim for specific transportation of 
pharmaceuticals to the desired site of action. By targeted 
delivery of drugs, solely to diseased cells, systemic side 
effects should be avoided. To enable specific delivery, 
a targeting ligand and its specific binding of the target 
cells as well as efficient intracellularization is necessary. 
The key advantage of such drug delivery systems is the 
ability to change pharmacokinetics. Additionally, the 
targeted distribution of drugs results in reduced effects 
on non-targeted tissues [106]. Aptamer-conjugated nano-
particles serving as targeting delivery systems commonly 
consist of iron oxid nanoparticles, gold nanoparticles, 
CNTs, dendrimers, quantum dots, liposomes or polymeric 
nanoparticles [106]. The drug can either be encapsulated 
within the nanoparticle or attached to the nanoparti-
cle surface [81, 107]. Zhang and coworkers developed 
an aptamer-nanoparticle conjugate for co-delivery of 
both, an entrapped and a surface-attached drug. The 
surface-attached drug release was approximately 80%, 
while the entrapped drug release was 45% in the same 
time interval. These properties may find application for 
time-controlled drug delivery [108]. Different research 
groups showed the effect of aptamer-functionalized and 
drug-loaded nanoparticles on cancer cells [89, 91]. For 
example, Aravind et  al. used polymeric nanoparticles 
consisting of poly(lactic-co-glycolic acid) (PGLA), loaded 
with paclitaxel (PTX) and immobilized with AS1411. They 
successfully targeted cancer cells in vitro. Additionally, 
they showed that cell viability of cancer cells decreased 
after incubation with aptamer-modified and drug-loaded 
particles. Thus, after targeting the cancer cells, drug 
release was induced [91].
Today there are many targeted drug delivery systems 
which are able to specifically enhance cellular uptake and 
increase cytotoxicity in vitro. Some groups have already 
investigated the applicability of aptamer-modified nano-
particles for targeted drug delivery in vivo. For example, 
Liu et  al. showed that aptamer-modified nanoparticles 
could accumulate at tumor sites in mice. They used ApS6 
and ApS10 directed against breast cancer cells and dem-
onstrated that the systemic toxicity to other organs was 
decreased, compared to systematic strategies of admin-
istration [109]. A problem which has to be solved, is the 
multicancer drug resistance. Multidrug resistance (MDR) 
hampers the efficacy of chemotherapy [110]. Utilization 
of aptamer-modified nanoparticles is one approach to 
solve this problem by enhancement of intracellular drug 
concentration in cancer cells can be achieved with nan-
oparticles. Simultaneously, the toxicity to healthy cells 
is minimal. Due to their small size, nanoparticles are 
able to cross the leaky and hyperpermeable tumor vas-
cular [111]. It is also possible to incorporate anticancer 
drugs and an additional chemosensitizer. Such delivery 
systems, consisting of two different drugs to overcome 
multi drug resistance have been reported. Sengupta and 
coworkers, for example, developed a nanoparticle deliv-
ery system loaded with combretastatin and doxorubicin 
Bereitgestellt von | Technische Informationsbibliothek (TIB)
Angemeldet
Heruntergeladen am | 12.07.17 10:30
12      Urmann et al.: Aptamer-modified nanomaterials: principles and applications
[112]. The drug attached to the nanoparticle surface was 
released first (combretastatin) and caused the destruction 
of tumors vasculature. Doxorubicin, which was entrapped 
within the nanoparticles, was released secondly and sub-
sequently caused cytotoxicity [112]. This may be a suitable 
approach to overcome MDR.
Intracellular sensing
While the aforementioned examples deal with the specific 
targeting of cell surface bound receptors, aptamer-modi-
fied nanoparticles can also be exploited for the detection 
of targets within cells. Different types of nanoparticles 
were already applied for intracellular imaging, such as 
quantum dots, silica nanoparticles or graphene oxide 
nanoparticles [113]. Furthermore, AgNPs, AuNPs and QDs 
functionalized with aptamers were used for intracellular 
protein imaging [114–116]. It is possible to target specific 
proteins and trace their endocytic pathway [114]. AuNPs 
are the most commonly used nanoparticles in intra-
cellular sensing. Zheng et  al. developed an assay with 
aptamer-modified AuNPs which could detect intracellular 
adenosine triphosphate (ATP) concentrations [117]. Wang 
and coworkers used aptamer-modified silica nanoparti-
cles to detect ATP [118]. They immobilized a Cy-5 labeled 
aptamer on nanoparticle surfaces and upon exposure to 
ATP, the aptamer changed its structure. Formation of an 
aptamer-target-complex induced the release of the immo-
bilized aptamer and finally a strong fluorescence signal is 
observed in the presence of ATP. If ATP is absent, no fluo-
rescence is detectable. The detection limit was reported to 
be ~34 µM [118].
Biosensing
Recently, aptamer-based biosensors (aptasensors) have 
attracted particular attention. The best known aptamer-
modified nanoparticles for biosensing are metallic nano-
particles like gold and silver nanoparticles [119]. Besides, 
aptamer-functionalized MNP are used for small-mole-
cule and protein detection (e.g. for detection of human 
R-thrombin protein, SPIONs were functionalized with 
aptamers) [80]. Aptamer-modified magnetic particles 
bind the target protein and MRI is used for detection. In 
presence of the target protein, a MRI contrast change is 
detectable [120].
There are three main categories of aptasensors: elec-
trochemical, optical and mass sensitive sensor systems 
[121]. Table 4 quotes different aptasensors, their detection 
limit, corresponding analyte targeted by the aptamer and 
application.
Mass sensitive aptasensors are a category of label-free 
bioassays which include wave-based sensors like surface-
plasmon resonance (SPR), acoustic wave-based sensors 
[quartz crystal microbalance (QCM)] and surface acous-
tic wave (SAW) sensors [121]. Mass sensitive aptasensors 
are capable of displaying changes on the sensor surface 
without any additional labeling. Furthermore, they can 
operate in real-time. Applications of mass sensitive 
aptasensors have been reported for the detection of large 
molecules like proteins or cells. Small molecules are hard 
to detect due to the minor change in mass induced by 
binding of small molecules to the sensor [104].
Optical sensors can be divided into fluorescent and 
colorimetric sensors [121]. Many colorimetric sensors are 
based on size dependent optical properties. An example 
Table 4: Different aptasensors for targeting biomolecules (continued).
Sensor   Detection limit   Target   Application   References
Colorimetric   –   Cocaine   AuNP   [122]
Colorimetric   20 nM   Thrombin   AuNP   [86]
Colorimetric   5 µM   Ibuprofen   AuNP   [123]
Colorimetric   17 nM   Glutathione   AuNP   [86, 124]
Fluorescence   5 nM   OTA   AuNP   [86]
Fluorescence   0.5 µM (signal-off mode)  Cocaine   QD   [125]
Fluorescence   10 µM   ATP   Graphene   [86]
Electrochemical   0.1 nM   ATP   AuNP   [86]
Electrochemical   0.5 µM   Cocaine   AuNP   [86]
Electrochemical   9.4 nM   Kanamycin   AuNP; self-assembled 
nano-composite
  [126]
Electrochemical   0.5 nM   Heavy metals  AuNP   [126]
Electrochemical   5 nM   BPA   AuNP   [126]
Fluorescent flow  5 mM   ATP   QD   [127]
FRET     OTA   AuNP   [128]
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for colorimetric sensing are aptamer-conjugated AuNPs 
[126]. Colloidal gold nanoparticles exhibit a red color and 
when they aggregate, their color changes to blue due to 
SPR effects [116, 129]. SPR is dependent on shape and 
particle size, as well as the distance between AuNPs; con-
sequently their absorption wavelength changes upon for-
mation of agglomerates [126].
Another example for a colorimetric aptasensor 
was demonstrated for the detection of digoxin. Herein, 
Emrani and coworkers used AuNPs and coupled aptam-
ers on the surface of the particles. When digoxin was 
absent, the aptamers were attached to the surface of 
the AuNPs by electrostatic interaction between aptamer 
and particles. Thus, the particles were stabilized against 
high salt-concentrations and consequently aggrega-
tion. In presence of digoxin, the aptamer changed its 
structure and an aptamer-digoxin-complex was formed. 
AuNPs aggregated after adding NaCl and the red colored 
colloidal AuNPs change their color into blue upon 
 aggregation [130].
Fluorescence-based biosensors could be designed 
with fluorescent labeled aptamers or with label-free 
aptamers [131]. Many fluorescence biosensors apply the 
competitive binding principle. This is based on the com-
petition of binding of the analyte or hybridization of a 
complementary strand to the aptamer. One example for 
competitive binding is a QD-based aptasensor for the 
detection of cocaine or the detection of human neutrophil 
elstase (HNE) [126, 132].
The fluorescence of the sensors could either be 
achieved by (i) direct modification of the aptamer with 
fluorophores, (ii) structural changes could cause fluores-
cence of a dye or (iii) the fluorescence resonance energy 
transfer (FRET) between two dyes could be affected [131]. 
As mentioned above, an example for a fluorescence-
based aptasensor was reported by Sharma et  al. for the 
detection of cocaine with aptamer-conjugated QDs [126]. 
Herein, distinction is made between two different types 
of sensors: signal-on and signal-off sensors. In case of 
the signal-on sensor, an oligonucleotide is labeled with 
the fluorescent dye Cy-5. FRET (between Cy-5 and QDs) 
quenches the signal and no fluorescence is detectable. 
If cocaine is present, an aptamer-cocaine-complex is 
formed resulting in the restoration of fluorescence exhib-
ited by the labeled oligonucleotide [125, 126, 131]. In case 
of the signal-off sensor, the aptamer is hybridized to a 
complementary (Cy-5 labeled) strand and coupled to the 
QD surface. If cocaine is absent, the fluorescence of Cy-5 
is detectable due to FRET between QD and Cy-5. In case of 
cocaine presence, the aptamer-target-complex is formed 
and the Cy-5 labeled oligonucleotide is released from the 
QD surface. Thus, decreased Cy-5 fluorescence signal indi-
cates the presence of cocaine [125, 126, 131].
Aptasensors can also be of electrochemical nature 
and implement aptamer-functionalized gold nanoparti-
cles. Li and coworkers self-assembled AuNPs on a gold 
electrode. Subsequently, the aptamer was immobilized on 
the nanoparticle surface and the electrical potential was 
measured. Upon detection of cocaine, a higher electrical 
potential was measured [133].
Conclusions
Potential applications of aptamer-modified nanoparticles 
or nanostructured materials are almost as multifarious 
as aptamer-sequences and their corresponding targets 
themselves. We believe that they will contribute to the 
solution of many analytical or other problems based on 
target recognition in the future. Even though the need 
of optimization for every aptamer-target pair and every 
utilized nanostructure persists, we are convinced that 
the set of considerations presented in this review can be 
a helpful resource when conjugating aptamers to nano-
particles or nanostructured surfaces. The applications 
presented here are demonstrating the success of such 
optimization processes for a wide range of cell-capture 
and biosensor applications based on aptamer-modified 
nanomaterials.
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